Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The University Of Shanghai For Science And Technology currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and is located within 1 distinct art unit. The university's active prosecution is currently limited to this application.
VARADARAJ, ARCHANA is the busiest examiner for the university, managing 1 pending office action. This action accounts for the total pending volume for the institution. Because the portfolio has only 1 distinct examiner and 1 distinct art unit, the prosecution strategy is focused on the specific requirements of the Biotechnology & Pharmaceuticals field as interpreted by VARADARAJ, ARCHANA.
The presence of 1 pending office action indicates a concentrated effort to advance this specific application. Practitioners can dedicate attention to the 1 distinct art unit involved, as no other units are currently reviewing pending actions for the university. The progress of the portfolio in this technology area depends on the resolution of the action held by VARADARAJ, ARCHANA.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.7% |
| VARADARAJ, ARCHANA | 1 | 66.7% | +50.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18989081 | METHOD FOR LOWERING CHOLESTEROL AND LIPID LEVELS USING THE ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER | HOFFMAN, SUSAN COE | — |
| 18539344 | CHOLECYSTOKININ (CCK) SECRETION-PROMOTING PEPTIDE TARGETING CALCIUM-SENSING RECEPTOR, AND PREPARATION METHOD AND USE THEREOF | VARADARAJ, ARCHANA | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18989081 | METHOD FOR LOWERING CHOLESTEROL AND LIPID LEVELS USING THE ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER | HOFFMAN, SUSAN COE | 1655 | §112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18539344 | CHOLECYSTOKININ (CCK) SECRETION-PROMOTING PEPTIDE TARGETING CALCIUM-SENSING RECEPTOR, AND PREPARATION METHOD AND USE THEREOF | VARADARAJ, ARCHANA | 1658 | §103 | Final Rejection | — | Pending | Dec 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity Of Shanghai For Science And Technology has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Susan Coe Hoffman has the most, with 1 of University Of Shanghai For Science And Technology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.